Skip to main content
. 2011 Jul 18;52(5):779–786. doi: 10.3349/ymj.2011.52.5.779

Table 4.

Clinical Course of Patients with Lung GvHD*

graphic file with name ymj-52-779-i004.jpg

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; FEV1, forced expiratory volume in 1s; FVC, forced vital capacity; NA, not available; IST, immunosuppressive treatment; GvHD, graft-versus-host disease.

*Mean follow-up duration since diagnosis of lung GvHD: 23.0 months (range: 6.2-36.3).